Skip to main content

Table 2 Changes in HbA1c (%), obesity measures and CVD risk factors at 3 months and 6 months

From: Behavioural Lifestyle Intervention Study (BLIS) in patients with type 2 diabetes in the United Arab Emirates: A randomized controlled trial

  Intervention (n = 18)a Control (n = 17)a
  3 months 6 months P valueb 3 months 6 months P valueb
HbA1c (%) (−) 1.56 ± 1.81c (−) 1.17 ± 2.11c 0.00 0.1 ± 1.37 (−)0.17 ± 1.79 0.74
Obesity measures       
 Weight (Kg) (−) 0.29 ± 3.12 (−) 0.72 ± 4.3 0.65 (−) 0.25 ± 1.22 (−) 0.41 ± 2.56 0.76
 BMI (Kg/m2) (−) 0.01 ± 1.1 0.14 ± 1.41 0.97 (−) 0.05 ± 0.54 0.14 ± 1.44 0.97
 Body composition       
  Fat mass (Kg) 0.00 ± 2.56 (−) 0.08 ± 3.73 0.98 (−) 1.21 ± 3.23 (−) 1.19 ± 3.91 0.26
  Muscle mass (Kg) (−) 0.09 ± 0.46 (−) 0.15 ± 0.49 0.35 0.27 ± 0.93 0.17 ± 0.83 0.49
  Water mass (Kg) (−) 0.14 ± 1.2 (−) 2.07 ± 7.17 0.34 0.99 ± 1.67 0.79 ± 1.36 0.03
CVD risk factors       
 HDL (mmol/L) 0.00 ± 0.13 (−) 0.01 ± 0.15 0.96 (−) 0.01 ± 0.17 (−) 0.01 ± 0.19 0.96
 LDL (mmol/L) (−) 0.08 ± 0.89 (−) 0.09 ± 0.95 0.86 (−) 0.17 ± 0.6 (−) 0.24 ± 0.77 0.21
 Total cholesterol (mmol/dL) 0.17 ± 0.69 (−) 0.13 ± 0.83 0.58 (−) 0.18 ± 0.63 (−) 0.14 ± 0.94 0.38
 Triglycerides (mmol/dL) (−) 0.37 ± 1.05 (−) 0.18 ± 0.76 0.14 (−) 0.09 ± 0.4 0.12 ± 0.78 0.43
 Systolic blood pressure ( mmHg) (−) 3.18 ± 11.67 (−) 1.71 ± 12.07 0.47 0.25 ± 13.16 3.13 ± 15.12 0.44
 Diastolic blood pressure (mmHg) (−) 0.18 ± 8.9 0.76 ± 7.48 0.89 2.50 ± 5.35 4.19 ± 8.48 0.12
  1. aData are presented as the mean ± standard deviation
  2. bOne-way ANOVA was used for between-groups comparisons, with a significance level of P < 0.05
  3. c P value < 0.0167 after Bonferroni correction